SANTA ROSA, Calif. – September 20, 2016 – Claret Medical®, an innovator in filter-based cerebral embolic protection technologies, today announced its filing of a marketing application with the US Food and Drug Administration (FDA) for clearance of the Sentinel® Cerebral Protection System (CPS).

FRISCO, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Michael Dinkins, executive vice president and chief financial officer, plans to leave the Company. The Company has commenced a search for his successor, and Mr. Dinkins will continue to serve as executive vice president and chief financial officer for up to six months or such earlier date when his successor is named.

WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted ‘nanosomes’ nanoparticles with recent funding from the National Institute of Allergy and Infectious Diseases (NIAID), NIH.

CAMPBELL, Calif. – September 7, 2016 – ZipLine® Medical, Inc., an innovator in skin closure, today announced results from a study recently published online in Pacing and Clinical Electrophysiology (PACE) showing significant efficiencies when Zip® Surgical Skin Closure is used following cardiac implantable electronic device (CIED) implantation. The Zip also demonstrated greater uniformity in closure technique, with no compromise in cosmetic outcomes or patient safety. 

Two PhD students, who secured sponsorship from leading medical device designer and manufacturer ITL, have revealed progress on the development of ground-breaking medical devices.

SAN DIEGO, July 12, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”), a company that develops and markets point of care ophthalmic in-vitro diagnostics, today recognized Shire plc on its recent US Food and Drug Administration (FDA) approval of Xiidra™ (lifitegrast ophthalmic solution) 5% for the treatment of signs and symptoms of Dry Eye Disease (DED).

BELGRADE, Mont. and DALLAS, June 08, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices and Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions, today announced a joint agreement to expand distribution of Pinnacle's InFill® Lateral Lumbar Interbody Fusion System. Through this agreement, Xtant enters the lateral lumbar interbody fusion market, expanding its spinal hardware portfolio.

SAN FRANCISCO, June 07, 2016 (GLOBE NEWSWIRE) -- Enable Injections Inc., the developer of wearable medical devices that enable easy, at-home self-administration of high volume injectable drugs and biologics, opens its new Cincinnati manufacturing facility this month, the company announced today at the BIO meeting in San Francisco.